Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FM8JC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,284
Award facts
- Contract value 100% obligated
- $9,284.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/1.2 ml powder vials. This firm fixed-price delivery order was issued on September 22, 2025, with an ultimate completion date of October 14, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. Performance will take place at the contractor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The contractor has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialty medications to Department of Defense healthcare sites. Xolair, a monoclonal antibody used primarily for moderate-to-severe allergic asthma and chronic idiopathic urticaria, represents a specialty pharmaceutical product consistent with the contractor's portfolio of advanced therapeutic agents supplied to federal health systems.
Quick answers
Who was awarded contract SPE2DB25FM8JC?
SPE2DB25FM8JC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FM8JC worth?
The government has obligated $9,284 on SPE2DB25FM8JC.
Is contract SPE2DB25FM8JC an order under another contract?
Yes. SPE2DB25FM8JC is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB25FM8JC competed?
The extent of competition for SPE2DB25FM8JC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award